Matches in SemOpenAlex for { <https://semopenalex.org/work/W2606581876> ?p ?o ?g. }
- W2606581876 endingPage "251" @default.
- W2606581876 startingPage "244" @default.
- W2606581876 abstract "Background Although the EORTC 18071‐trial has shown a clear survival benefit for adjuvant ipilimumab, accurately selecting patients for this toxic adjuvant therapy is important. We aimed to identify prognostic factors for death and disease recurrence in AJCC stage IIIC melanoma patients. Patients and Methods Retrospective analysis of patients who underwent lymph node dissection (LND) for stage IIIC melanoma in our institution between 2000 and 2016. Baseline characteristics, melanoma‐specific survival (MSS), and disease‐free survival (DFS) were assessed, and prognostic factors for recurrence and survival were analyzed using uni‐ and multivariable analysis. Results A total of 205 patients were included. Median follow‐up was 20 months (interquartile range 11‐43 months), median MSS was 28 months, and median DFS was 11 months. Five‐year MSS was 33% and 5‐year DFS was 23%. N3 (≥4 involved lymph nodes) and extracapsular extension (ECE) carried an increased risk of disease recurrence after LND and death by melanoma. Patients with both N3 and ECE had virtually no long‐term survival. Conclusions Although survival for patients with stage IIIC is poor in general, patients with both N3 disease and ECE constitute the group with the worst prognosis and should be considered for adjuvant therapy with ipilimumab or any other future effective adjuvant therapy (study)." @default.
- W2606581876 created "2017-04-28" @default.
- W2606581876 creator A5011423603 @default.
- W2606581876 creator A5024566513 @default.
- W2606581876 creator A5058061659 @default.
- W2606581876 creator A5061565581 @default.
- W2606581876 creator A5063789306 @default.
- W2606581876 creator A5073219721 @default.
- W2606581876 creator A5075441317 @default.
- W2606581876 creator A5086335455 @default.
- W2606581876 date "2017-04-15" @default.
- W2606581876 modified "2023-10-16" @default.
- W2606581876 title "Clinical prognostic markers in stage IIIC melanoma" @default.
- W2606581876 cites W1524268525 @default.
- W2606581876 cites W1985325086 @default.
- W2606581876 cites W2000481486 @default.
- W2606581876 cites W2012045487 @default.
- W2606581876 cites W2013334144 @default.
- W2606581876 cites W2031218167 @default.
- W2606581876 cites W2068644645 @default.
- W2606581876 cites W2070825440 @default.
- W2606581876 cites W2097995306 @default.
- W2606581876 cites W2118863192 @default.
- W2606581876 cites W2121779742 @default.
- W2606581876 cites W2128035403 @default.
- W2606581876 cites W2152897456 @default.
- W2606581876 cites W2156078931 @default.
- W2606581876 cites W2161204007 @default.
- W2606581876 cites W2167925208 @default.
- W2606581876 cites W2418833024 @default.
- W2606581876 cites W2529373149 @default.
- W2606581876 cites W2580675613 @default.
- W2606581876 doi "https://doi.org/10.1002/jso.24635" @default.
- W2606581876 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28411392" @default.
- W2606581876 hasPublicationYear "2017" @default.
- W2606581876 type Work @default.
- W2606581876 sameAs 2606581876 @default.
- W2606581876 citedByCount "7" @default.
- W2606581876 countsByYear W26065818762018 @default.
- W2606581876 countsByYear W26065818762019 @default.
- W2606581876 countsByYear W26065818762020 @default.
- W2606581876 countsByYear W26065818762022 @default.
- W2606581876 crossrefType "journal-article" @default.
- W2606581876 hasAuthorship W2606581876A5011423603 @default.
- W2606581876 hasAuthorship W2606581876A5024566513 @default.
- W2606581876 hasAuthorship W2606581876A5058061659 @default.
- W2606581876 hasAuthorship W2606581876A5061565581 @default.
- W2606581876 hasAuthorship W2606581876A5063789306 @default.
- W2606581876 hasAuthorship W2606581876A5073219721 @default.
- W2606581876 hasAuthorship W2606581876A5075441317 @default.
- W2606581876 hasAuthorship W2606581876A5086335455 @default.
- W2606581876 hasConcept C10515644 @default.
- W2606581876 hasConcept C119060515 @default.
- W2606581876 hasConcept C121608353 @default.
- W2606581876 hasConcept C126322002 @default.
- W2606581876 hasConcept C141071460 @default.
- W2606581876 hasConcept C143998085 @default.
- W2606581876 hasConcept C146357865 @default.
- W2606581876 hasConcept C151730666 @default.
- W2606581876 hasConcept C167135981 @default.
- W2606581876 hasConcept C2777658100 @default.
- W2606581876 hasConcept C2777701055 @default.
- W2606581876 hasConcept C2777863537 @default.
- W2606581876 hasConcept C2777982462 @default.
- W2606581876 hasConcept C2780849966 @default.
- W2606581876 hasConcept C2781433595 @default.
- W2606581876 hasConcept C502942594 @default.
- W2606581876 hasConcept C71924100 @default.
- W2606581876 hasConcept C86803240 @default.
- W2606581876 hasConceptScore W2606581876C10515644 @default.
- W2606581876 hasConceptScore W2606581876C119060515 @default.
- W2606581876 hasConceptScore W2606581876C121608353 @default.
- W2606581876 hasConceptScore W2606581876C126322002 @default.
- W2606581876 hasConceptScore W2606581876C141071460 @default.
- W2606581876 hasConceptScore W2606581876C143998085 @default.
- W2606581876 hasConceptScore W2606581876C146357865 @default.
- W2606581876 hasConceptScore W2606581876C151730666 @default.
- W2606581876 hasConceptScore W2606581876C167135981 @default.
- W2606581876 hasConceptScore W2606581876C2777658100 @default.
- W2606581876 hasConceptScore W2606581876C2777701055 @default.
- W2606581876 hasConceptScore W2606581876C2777863537 @default.
- W2606581876 hasConceptScore W2606581876C2777982462 @default.
- W2606581876 hasConceptScore W2606581876C2780849966 @default.
- W2606581876 hasConceptScore W2606581876C2781433595 @default.
- W2606581876 hasConceptScore W2606581876C502942594 @default.
- W2606581876 hasConceptScore W2606581876C71924100 @default.
- W2606581876 hasConceptScore W2606581876C86803240 @default.
- W2606581876 hasIssue "2" @default.
- W2606581876 hasLocation W26065818761 @default.
- W2606581876 hasLocation W26065818762 @default.
- W2606581876 hasOpenAccess W2606581876 @default.
- W2606581876 hasPrimaryLocation W26065818761 @default.
- W2606581876 hasRelatedWork W1983580311 @default.
- W2606581876 hasRelatedWork W1995530667 @default.
- W2606581876 hasRelatedWork W2060473360 @default.
- W2606581876 hasRelatedWork W2324811517 @default.
- W2606581876 hasRelatedWork W2396554325 @default.
- W2606581876 hasRelatedWork W2752227448 @default.